CD8A and neoplasm: In conclusion, this paper provides the first in vivo evidence, to our knowledge, that the blockade of TGF-β inhibits the initial generation of functionally active anti-tumor CTLs and antigen-specific CD8+ T cells after Ad.E7 vaccination.